GlaxoSmithKline Pharma Q1 dips 5 per cent to Rs 93 crore
Net sales declined to Rs 621.85 crore for the first quarter, as compared to Rs 654.96 crore in the same period of previous financial year.
By PTI |
NEW DELHI: GlaxoSmithKline Pharmaceuticals today reported 5.09 per cent decline in its net profit at Rs 93.28 crore for the first quarter ended June 30, hit by supply constraints.
The company had posted a net profit of Rs 98.29 crore for the same period of previous fiscal.
Net sales of the company also declined to Rs 621.85 crore for the first quarter, as compared to Rs 654.96 crore in the same period of previous financial year, GlaxoSmithKline Pharmaceuticals said in a filing to the BSE.
"The quarterly performance was impacted by supply constraints," it added.
The company's stock was trading at Rs 3,482.35, down 1.20 per cent, on the BSE.
The company had posted a net profit of Rs 98.29 crore for the same period of previous fiscal.
Net sales of the company also declined to Rs 621.85 crore for the first quarter, as compared to Rs 654.96 crore in the same period of previous financial year, GlaxoSmithKline Pharmaceuticals said in a filing to the BSE.
"The quarterly performance was impacted by supply constraints," it added.
The company's stock was trading at Rs 3,482.35, down 1.20 per cent, on the BSE.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
